|
|
|
Insider
Information: |
Schenkein David P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
178,178 |
|
Indirect Shares
|
417,826 |
|
|
Direct
Value |
$6,734,804 |
|
|
Indirect Value
|
$17,699,944 |
|
|
Total
Shares |
596,004 |
|
|
Total
Value |
$24,434,748 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-300.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-06-13 |
126,242 |
2024-06-13 |
349,854 |
Premium* |
|
Foundation Medicine, Inc. |
FMI |
Director |
2016-06-16 |
23,326 |
2016-06-16 |
10,508 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
|
2020-06-18 |
6,832 |
2014-12-19 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-31 |
21,496 |
2024-05-31 |
57,464 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
282 |
2023-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
155 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-11-01 |
4 |
AS |
$63.32 |
$383,105 |
D/D |
(6,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-12-01 |
4 |
AS |
$61.51 |
$369,288 |
D/D |
(6,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-12-01 |
4 |
OE |
$0.30 |
$1,815 |
D/D |
6,000 |
6,000 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2017-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
249,998 |
19,774 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-16 |
4 |
OE |
$0.30 |
$16,033 |
D/D |
53,000 |
53,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-16 |
4 |
AS |
$71.77 |
$3,877,218 |
D/D |
(53,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-23 |
4 |
OE |
$0.30 |
$9,945 |
D/D |
32,875 |
32,875 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-23 |
4 |
AS |
$80.01 |
$2,630,329 |
D/D |
(32,875) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
AS |
$80.01 |
$1,600 |
D/D |
(20) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
OE |
$0.30 |
$6 |
D/D |
20 |
20 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
AS |
$80.01 |
$1,082,775 |
D/D |
(13,533) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
OE |
$0.30 |
$4,094 |
D/D |
13,533 |
13,533 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-26 |
4 |
OE |
$0.30 |
$7,131 |
D/D |
23,572 |
23,572 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-26 |
4 |
AS |
$80.35 |
$1,911,494 |
D/D |
(23,572) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-02-01 |
4 |
AS |
$78.50 |
$1,023,756 |
D/D |
(13,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-02-01 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-03-01 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-03-01 |
4 |
AS |
$80.38 |
$1,054,218 |
D/D |
(13,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-04-02 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-04-02 |
4 |
AS |
$75.54 |
$1,010,357 |
D/D |
(13,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-01 |
4 |
AS |
$82.88 |
$1,079,501 |
D/D |
(13,000) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-01 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-23 |
4 |
OE |
$0.30 |
$14,936 |
D/D |
49,374 |
49,374 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-23 |
4 |
AS |
$90.11 |
$4,463,524 |
D/D |
(49,374) |
0 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-30 |
4 |
OE |
$0.30 |
$17,675 |
D/D |
45,626 |
45,626 |
0 |
- |
|
155 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|